Inactivated Japanese Encephalitis Virus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Tsai, Theodore F.

doi:10.1037/e546842006-001

Cited by 43 publications

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Vaccines for preventing Japanese encephalitis

Schiøler

Melamed²,

Wai³

2007

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Only one of the three currently used vaccines has been assessed for efficacy in a RCT. Other RCTs have assessed their safety, however, and they appear to cause only occasional mild or moderate adverse events. Further trials of effectiveness and safety are needed for the currently used vaccines, especially concerning dose levels and schedules. Trials investigating several new vaccines are planned or in progress.

show abstract

Vaccines for preventing Japanese encephalitis

Schiøler

Melamed²,

Wai³

2007

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

show abstract

Control of Japanese encephalitis in India: A reality

Kabilan

2004

Indian J Pediatr

View full text Add to dashboard Cite

Japanese encephalitis is considered as a serious disease due to the complexity of the disease and lack of specific treatment. A secular trend towards declining of JE has been brought in China, Korea, and Japan with widespread use of JE vaccine. In India, the actual JE burden could be estimated only by strengthening diagnostic facilities for JE confirmation in hospitals. However, the available records at present indicate a rising trend in JE- occurrence and expansion of the disease into JE non-endemic areas, which cannot be ignored. JE control through vector control methods has limitations owing to sustainability and cost effectiveness of the programs. Under these circumstances, feasibility of JE vaccination in India has to be considered as a preventive measure, for which identification of risk areas, target populations to be immunized, cost-evaluation of immunization is emphasized. Since, JE vaccine is produced in India, extension of the availability of this vaccine into routine JE-immunization programs is not remote. China has proved that countries with limited sources can produce safe and effective JE vaccines.

show abstract

Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis

2016

View full text Add to dashboard Cite

Arboviruses are arthropod-borne viruses that exhibit worldwide distribution, contributing to systemic and neurologic infections in a variety of geographical locations. Arboviruses are transmitted to vertebral hosts during blood feedings by mosquitoes, ticks, biting flies, mites, and nits. While the majority of arboviral infections do not lead to neuroinvasive forms of disease, they are among the most severe infectious risks to the health of the human central nervous system. The neurologic diseases caused by arboviruses include meningitis, encephalitis, myelitis, encephalomyelitis, neuritis, and myositis in which virus-and immune-mediated injury may lead to severe, persisting neurologic deficits or death. Here we will review the major families of emerging arboviruses that cause neurologic infections, their neuropathogenesis and host neuroimmunologic responses, and current strategies for treatment and prevention of neurologic infections they cause.

show abstract

Inactivated Japanese Encephalitis Virus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Cited by 43 publications

References 20 publications

Vaccines for preventing Japanese encephalitis

Vaccines for preventing Japanese encephalitis

Control of Japanese encephalitis in India: A reality

Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis

Contact Info

Product

Resources

About